Launch Overview
Project Serotonin announced the launch of its tenth‑generation Preventive Health Platform and the accompanying Precision Health Operating System (OS) during the recently concluded RISE for Healthy Aging conference, held at the Indian Institute of Science (IISc) in Bengaluru. The announcement was made through a press release dated Thursday, 13 August 2026.
Platform Design and Capabilities
The Platform is positioned as a modular, ready‑to‑deploy infrastructure that enables large hospitals, multispecialty hospitals, clinic networks, and longevity centres to deliver continuous, personalised preventive care. It creates a connective layer that aggregates diagnostics, genomics, blood biomarkers, wearable data, clinical records and practitioner insights into a single model of care. Rather than replacing existing clinical pathways, the Platform adds a structured prevention layer that supports risk stratification, protocol design, patient engagement, monitoring and behaviour change while allowing clinicians to continue practising as before.
Precision Health OS Features
At the core of the solution is Project Serotonin’s proprietary Precision Health OS, an orchestration engine that evaluates each individual’s genetic predispositions, biomarker trajectories, wearable trends, lifestyle patterns, pharmacogenetic considerations and clinical history as a unified health profile. The OS incorporates safeguards for contraindications, drug‑drug interactions and escalation pathways, and enforces data security through anonymisation, encryption and role‑based access controls. The intelligence generated by the OS is operationalised through the SRTN Precision Daily Operating System (SRTN‑pDOS), which translates complex biological information into structured, practitioner‑guided protocols across two care formats: foundational preventive care and therapy‑adjunct protocols (e.g., gut health, cardiovascular health).
Evidence Base and Protocol Content
The precision protocols draw on an evidence base of more than 44,000 stratified clinical studies and have been refined through real‑world pilot implementations. They cover nutrition, supplementation, physical activity, sleep, stress management and other modifiable health behaviours. Recommendations are delivered via the SRTN mobile application and are supported by care‑concierge teams and health coaches who assist individuals in sustaining adherence over time.
Market Need and Impact Estimates
The press release cites World Health Organization data indicating that non‑communicable diseases account for nearly 75 % of all deaths globally. In India, these diseases tend to manifest three to ten years earlier than in developed nations, and multimorbidity has risen sharply over the past three decades. An EY–FICCI assessment referenced in the release concluded that appropriate preventive interventions could reduce hospitalisations in India by 20 % to 30 %.
Engagement Architecture
Project Serotonin notes that adherence rates for regular preventive therapies in developed countries can be as low as 28 %, highlighting the challenge of long‑term engagement. To address this, the Platform’s engagement architecture integrates twelve traditionally isolated systems, including diagnostics, genomics, wearable intelligence, a clinician console, Rx Intelligence screened against more than 2,600 drugs, patient engagement tools, fulfillment, adherence coaching and operational management. Institutions may deploy the full Platform or adopt individual modules at their own pace.
Leadership Quote
"We are at an inflection point in human health. Project Serotonin is built for the Medicine 4.0 era, which is defined not by how much data we collect, but by how intelligently we connect it," said Dr Ashwat Visvanathan (PhD), Head – Partnerships and User Outcomes, Project Serotonin. He added that the Platform enables healthcare providers to shift from episodic treatment to plug‑and‑play precision prevention without disrupting existing systems and clinical expertise.
Company Background
Project Serotonin is a preventive health technology company headquartered in San Francisco and Bengaluru. Over ten years of research and development, the company has invested more than 300,000 hours in R&D covering micronutrient quantification, formulation, dosage, frequency, combination, exercise, sleep, fasting, diet and lifestyle protocols. The firm’s mission is to make measurable, personalised preventive health accessible to millions through trusted health and wellness partners.